Arcus Biosciences Inc (RCUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 156,000 | 185,000 | 127,000 | 184,000 | 230,000 |
| Marketable Securities | 813,000 | 810,000 | 632,000 | 615,000 | 700,000 |
| Receivables | 28,000 | 35,000 | 38,000 | 52,000 | 34,000 |
| TOTAL | $1,022,000 | $1,064,000 | $831,000 | $882,000 | $986,000 |
| Non-Current Assets | |||||
| PPE Net | 49,000 | 51,000 | 51,000 | 50,000 | 45,000 |
| Investments And Advances | 40,000 | 100,000 | 107,000 | 151,000 | 80,000 |
| Other Non-Current Assets | 75,000 | 78,000 | 106,000 | 108,000 | 109,000 |
| TOTAL | $164,000 | $229,000 | $264,000 | $309,000 | $234,000 |
| Total Assets | $1,186,000 | $1,293,000 | $1,095,000 | $1,191,000 | $1,220,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,000 | 16,000 | 17,000 | 17,000 | 12,000 |
| Other current liabilities | 71,000 | 64,000 | 76,000 | 80,000 | 65,000 |
| TOTAL | $199,000 | $204,000 | $184,000 | $200,000 | $180,000 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 113,000 | 124,000 | 91,000 | 103,000 | 103,000 |
| Other Non-Current Liabilities | 138,000 | 140,000 | 142,000 | 145,000 | 144,000 |
| TOTAL | $352,000 | $382,000 | $449,000 | $471,000 | $474,000 |
| Total Liabilities | $551,000 | $586,000 | $633,000 | $671,000 | $654,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 91,428 | 90,953 | 90,865 | 74,856 | 74,504 |
| Common Shares | 1,582,000 | 1,561,000 | 1,311,000 | 1,291,000 | 1,267,000 |
| Retained earnings | -946,000 | -853,000 | -849,000 | -768,000 | -697,000 |
| Other shareholders' equity | -1,000 | -1,000 | 0 | -3,000 | -4,000 |
| TOTAL | $635,000 | $707,000 | $462,000 | $520,000 | $566,000 |
| Total Liabilities And Equity | $1,186,000 | $1,293,000 | $1,095,000 | $1,191,000 | $1,220,000 |